Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of injectable GMDTC in adults with elevated cadmium levels
CTR20252512Phase 2Completed
- Sponsor
- GenSheng Pharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gmdtc in cadmium poisoning, lead poisoning, heavy metal poisoning, sponsored by GenSheng Pharmaceutical. Started Jul 2025; status: completed.
02
Drugs
gmdtc
03
Conditions
cadmium poisoninglead poisoningheavy metal poisoning
Beyond the preview
Go deeper on CTR20252512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252512.